Indication · Cardiology
Coronary artery disease
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
642
Cleared or approved since 2000
PMA and De Novo
262
Higher-risk or first-of-kind devices
Breakthrough devices
2
Authorized through June 30, 2026
Recruiting device trials
212
2,148 device trials in all
Breakthrough-designated devices
- Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) CatShockwave Medical, Inc. · 2026
1 more devices with a free account
Devices
642 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Liposorber(R) LA-15 System Adsorption Column
Kaneka Pharma America Corp. · PMA · Lipoprotein, Low Density, Removal · newest 2025 · 15 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMIPivotal-lookingRecruiting
Hospital Universitario La FeAcademic, hospital or other
NCT06353594 · 1,272 participants (planned) · Start Mar 11, 2024 · Primary completion Mar 2028
Device: Primary PCI · For: ST Elevation Myocardial Infarction
Sites: Huelva, Spain; Valencia, Spain; A Coruña, Spain · 23 sites in all
2,147 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX)113
- Stent, Coronary (MAF)71
- Coronary Drug-Eluting Stent (NIQ)63
- Catheter For Crossing Total Occlusions (PDU)49
- System, Imaging, Optical Coherence Tomography (Oct) (NQQ)35
- Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl (LBS)31
- Catheter, Coronary, Atherectomy (MCX)26
- Transducer, Pressure, Catheter Tip (DXO)23
- Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC)21
- Device, Counter-Pulsating, External (DRN)21
- Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection (NFA)18
- Cardiac C-Reactive Protein, Antigen, Antiserum, And Control (NQD)18
- System, Test, Low Density, Lipoprotein (MRR)17
- System, Catheter Control, Steerable (DXX)16
- Device, Angioplasty, Laser, Coronary (LPC)12
- System, Laser, Transmyocardial Revascularization (MNO)11
- Intravascular Radiation Delivery System (MOU)10
- Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring (NWX)9
- Percutaneous Catheter, Ultrasound (PPN)7
- X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device (QHA)7
- Coronary Vascular Physiologic Simulation Software (PJA)6
- Ldl & Vldl Precipitation, Hdl (LBR)5
- Monitor, St Segment With Alarm (MLD)5
- Lipoprotein, Low Density, Removal (MMY)5
- Apolipoproteins (MSJ)5
- Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2 (NOE)4
- Catheter, Intravascular, Plaque Morphology Evaluation (OGZ)4
- Clip, Implantable, For Coronary Artery Bypass Graft (Cabg) (NCA)3
- Stabilizer, Heart, Non-Compression, Reprocessed (NQG)3
- Marker, Cardiopulmonary Bypass (Vein Marker) (MAB)2
Research
- Device studies on coronary artery disease across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.